Gyon Technologies Capital Management, LP Sarepta Therapeutics, Inc. Transaction History

Gyon Technologies Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $146,953 - $192,513	1,457 Added 24.36%	7,439 $963,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $452,897 - $713,293	5,982 New	5,982 $661,000
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $218,856 - $281,557	-2,832 Closed	0 $0
Q3 2021 Nov 18, 2021	SELL	$65.97 - $92.48 $1.36 Million - $1.91 Million	-20,684 Reduced 87.96%	2,832 $262,000
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $1.63 Million - $2.04 Million	23,516 New	23,516 $1.83 Million

536

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.73B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.